Solventum Corporation (SOLV) Stock Analysis

Q: What is the SOLV stock price target?

Take-profit $73.24 (+11.7% upside). Prior stop was $62.20.

Q: What are the risks of investing in SOLV?

Concentration risk — Supplier: 3M; Leverage penalty (D/E 1.0): -0.5; Earnings in 5 days (event risk); Momentum score 1.7/10 — below 4.5 minimum; Death cross — 50-day MA below 200-day MA.

Q: Is SOLV overvalued or undervalued?

Solventum Corporation trades at a P/E of 7.5 (forward 9.5). TrendMatrix value score: 7.3/10. Overall verdict: Sell.

Q: What do analysts say about SOLV?

21 analysts cover SOLV with a consensus score of 3.7/5. Average price target: $84.

Range Bound setup

SellModerate ConfidenceUpdated 2026-04-30

Healthcare · Medical Instruments & Supplies

Earnings in 5 days (2026-05-05). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Momentum 1.7/10 is below the 5.0 floor at $65.75 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.0): -0.5; Concentration risk — Supplier: 3M.

Solventum is a healthcare company spun off from 3M in 2024, developing and commercializing solutions in wound care, procedural equipment, dental products, and health information systems. Three segments: MedSurg (57.9% of 2025 sales), Dental Solutions (16.2%), and Health... Read more

$65.75+11.7% A.UpsideScore 5.5/10#7 of 25 Medical Instruments & Supplies

Stop $62.20Target $73.24(analyst − 13%)A.R:R 2.3:1

Analyst target$84.18+28.0%11 analysts

$73.24our TP

$65.75price

$84.18mean

$60

$105

Passes 4/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: moderate.

Thesis

Rewards

Strong earnings beat streak (4/4)

Attractive valuation

Margin of safety: 50%

Risks

Concentration risk — Supplier: 3M

Leverage penalty (D/E 1.0): -0.5

Earnings in 5 days (event risk)

Key Metrics

P/E (TTM)7.5

P/E (Fwd)9.5

Mkt Cap$11.5B

EV/EBITDA13.6

Profit Mgn18.7%

ROE38.9%

Rev Growth-3.7%

Beta0.77

DividendNone

Rating analysts21

Quality Signals

Piotroski F4/9

Options Flow

P/C0.30bullish

IV62%elevated

Max Pain$50-24.0% vs spot

Concentration Risks(10-K Item 1A)

HIGHSupplier3M
10-K Item 1A: 'Solventum continues to have significant commercial relationships with 3M'

Material Events(8-K, last 90d)

2026-03-24Item 5.02MEDIUM
Mary Wilcox, Chief Accounting Officer of Solventum Corporation, announced intent to retire effective following a search for and appointment of her successor, as of March 20, 2026. No successor named; search underway.
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value7.315%1.09

Quality5.415%0.81

Growth5.815%0.87

Momentum1.710%0.17

Sentiment7.310%0.73

Insider Activity5.010%0.50

Peer Rank4.410%0.44

Technical Setup6.15%0.30

Risk Profile6.15%0.30

Catalyst6.05%0.30

Overall (Σ contributions)5.52

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume

0.0

Obv

1.0

Ma Position

1.0

Macd

1.9

Rsi

4.5

Volume distribution (falling OBV)Below 200-MA, MA slope -1.7%/30d — confirmed downtrend

GatesMomentum 1.7<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 5d<=7dA.R:R 2.3 ≥ 1.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARRange BoundSuitability: Moderate

RSI

49 · Neutral

↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $62.38Resistance $71.42

Price Targets

$62

$73

A.Upside+11.4%

A.R:R2.3:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Momentum score 1.7/10 — below 4.5 minimum

! Death cross — 50-day MA below 200-day MA

! EARNINGS_PROXIMITY:5d<=7d

Earnings

4/4 beats

Next Earnings2026-05-05 (5d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is SOLV stock a buy right now?

Sell if holding. Momentum 1.7/10 is below the 5.0 floor at $65.75 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.0): -0.5; Concentration risk — Supplier: 3M. Chart setup: RSI 49 mid-range, Bollinger mid-band. Prior stop was $62.20. Score 5.5/10, moderate confidence.

What is the SOLV stock price target?

Take-profit target: $73.24 (+11.7% upside). Prior stop was $62.20. Stop-loss: $62.20.

What are the risks of investing in SOLV?

Concentration risk — Supplier: 3M; Leverage penalty (D/E 1.0): -0.5; Earnings in 5 days (event risk).

Is SOLV overvalued or undervalued?

Solventum Corporation trades at a P/E of 7.5 (forward 9.5). TrendMatrix value score: 7.3/10. Verdict: Sell.

What do analysts say about SOLV?

21 analysts cover SOLV with a consensus score of 3.7/5. Average price target: $84.

What does Solventum Corporation do?Solventum is a healthcare company spun off from 3M in 2024, developing and commercializing solutions in wound care,...